Please login to the form below

Not currently logged in
Email:
Password:

Ergomed appoints Andrew Mackie as chief business officer

He is also inducted as executive director to the board

UK-based Ergomed has named Andrew Mackie as chief business officer and executive director to its board.

Mackie brings over 25 years of experience in pre clinical research, clinical and business development to the role and has held a number of senior R&D roles at Novartis and Sanofi. 

He joins from Lilly, where he was part of the business development team.

Miroslav Reljanovic, CEO at Ergomed, commented: “Over the past ten years, Andrew has worked with Ergomed as a consultant, and has been instrumental in developing the co-development business model, acting as lead negotiator on the partnerships signed to date. 

“His successful track record in drug development and deal making not only strengthens our capabilities as we continue to advance our co-development pipeline but ensures we have the right team in place as we look to expand through organic growth and acquisitions.”

After ten years in R&D, Mackie joined the UK biotech sector in 1997 at oncology specialist Antisoma, where he established the clinical development department and transitioned new molecules into development.

Ergomed provides specialised services to the pharma industry and the development of new drugs. 

6th July 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics